XML 59 R23.htm IDEA: XBRL DOCUMENT v3.19.3
Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Schedule of Cash, Cash Equivalents, and Restricted Cash The following represents a reconciliation of cash and cash equivalents in the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash in the unaudited condensed consolidated statements of cash flows:
In millions
September 30,
2019
    
December 31,
2018
Cash and cash equivalents
$
5,193

 
$
4,059

Restricted cash (included in other current assets)
6

 
6

Restricted cash (included in other assets)
270

 
230

Total cash, cash equivalents and restricted cash in the statements of cash flows
$
5,469

 
$
4,295


Accounts Receivable, Net Accounts receivable, net is composed of the following:
In millions
September 30,
2019
    
December 31,
2018
Trade receivables
$
6,413

 
$
6,497

Vendor and manufacturer receivables
9,029

 
7,315

Premium receivables
2,340

 
2,259

Other receivables
2,007

 
1,560

   Total accounts receivable, net
$
19,789

 
$
17,631


Disaggregation of Revenue
The following tables disaggregate the Company’s revenue by major source in each segment for the three and nine months ended September 30, 2019 and 2018:
In millions
Pharmacy
Services
    
Retail/
LTC
    
Health Care
Benefits
 
Corporate/
Other
 
Intersegment
Eliminations
    
Consolidated
Totals
Three Months Ended September 30, 2019
 
 
 
 
 
 
 
 
 
 
Major goods/services lines:
 
 
 
 
 
 
 
 
 
 
 
Pharmacy
$
35,872

 
$
16,687

 
$

 
$

 
$
(10,007
)
 
$
42,552

Front Store

 
4,614

 

 

 

 
4,614

Premiums

 

 
15,507

 
32

 

 
15,539

Net investment income

 

 
146

 
117

 

 
263

Other
146

 
165

 
1,528

 
3

 

 
1,842

Total
$
36,018

 
$
21,466

 
$
17,181

 
$
152

 
$
(10,007
)
 
$
64,810

 
 
 
 
 
 
 
 
 
 
 
 
Pharmacy Services distribution channel:
 
 
 
 
 
 
 
 
 
 
Pharmacy network (1)
$
22,469

 
 
 
 
 
 
 
 
 
 
Mail choice (2)
13,403

 
 
 
 
 
 
 
 
 
 
Other
146

 
 
 
 
 
 
 
 
 
 
Total
$
36,018

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended September 30, 2018
 
 
 
 
 
 
 
 
 
 
Major goods/services lines:
 
 
 
 
 
 
 
 
 
 
 
Pharmacy
$
33,733

 
$
16,123

 
$

 
$

 
$
(8,088
)
 
$
41,768

Front Store

 
4,557

 

 

 

 
4,557

Premiums

 

 
627

 

 

 
627

Net investment income

 

 
4

 
217

 

 
221

Other
131

 
176

 
10

 

 

 
317

Total
$
33,864

 
$
20,856

 
$
641

 
$
217

 
$
(8,088
)
 
$
47,490

 
 
 
 
 
 
 
 
 
 
 
 
Pharmacy Services distribution channel:
 
 
 
 
 
 
 
 
 
 
Pharmacy network (1)
$
21,921

 
 
 
 
 
 
 
 
 
 
Mail choice (2)
11,812

 
 
 
 
 
 
 
 
 
 
Other
131

 
 
 
 
 
 
 
 
 
 
Total
$
33,864

 
 
 
 
 
 
 
 
 
 
_____________________________________________ 
(1)
Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company’s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice® activity, which is included within the mail choice category.
(2)
Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail facility, which includes specialty mail claims inclusive of Specialty Connect® claims picked up at a CVS Pharmacy retail store, as well as prescriptions filled at the Company’s retail pharmacies under the Maintenance Choice program, which permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.

In millions
Pharmacy
Services
    
Retail/
LTC
    
Health Care
Benefits
 
Corporate/
Other
 
Intersegment
Eliminations
    
Consolidated
Totals
Nine Months Ended September 30, 2019
 
 
 
 
 
 
 
 
 
 
Major goods/services lines:
 
 
 
 
 
 
 
 
 
 
 
Pharmacy
$
103,983

 
$
49,197

 
$

 
$

 
$
(31,436
)
 
$
121,744

Front Store

 
14,288

 

 

 

 
14,288

Premiums

 

 
47,543

 
69

 

 
47,612

Net investment income

 

 
458

 
347

 

 
805

Other
435

 
543

 
4,453

 
7

 

 
5,438

Total
$
104,418

 
$
64,028

 
$
52,454

 
$
423

 
$
(31,436
)
 
$
189,887

 
 
 
 
 
 
 
 
 
 
 
 
Pharmacy Services distribution channel:
 
 
 
 
 
 
 
 
 
 
Pharmacy network (1)
$
66,071

 
 
 
 
 
 
 
 
 
 
Mail choice (2)
37,912

 
 
 
 
 
 
 
 
 
 
Other
435

 
 
 
 
 
 
 
 
 
 
Total
$
104,418

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nine Months Ended September 30, 2018
 
 
 
 
 
 
 
 
 
 
Major goods/services lines:
 
 
 
 
 
 
 
 
 
 
 
Pharmacy
$
99,432

 
$
47,428

 
$

 
$

 
$
(24,840
)
 
$
122,020

Front Store

 
13,990

 

 

 

 
13,990

Premiums

 

 
2,684

 

 

 
2,684

Net investment income

 

 
10

 
475

 

 
485

Other
405

 
542

 
29

 

 

 
976

Total
$
99,837

 
$
61,960

 
$
2,723

 
$
475

 
$
(24,840
)
 
$
140,155

 
 
 
 
 
 
 
 
 
 
 
 
Pharmacy Services distribution channel:
 
 
 
 
 
 
 
 
 
 
Pharmacy network (1)
$
64,625

 
 
 
 
 
 
 
 
 
 
Mail choice (2)
34,807

 
 
 
 
 
 
 
 
 
 
Other
405

 
 
 
 
 
 
 
 
 
 
Total
$
99,837

 
 
 
 
 
 
 
 
 
 
_____________________________________________ 
(1)
Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company’s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice® activity, which is included within the mail choice category.
(2)
Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail facility, which includes specialty mail claims inclusive of Specialty Connect® claims picked up at a CVS Pharmacy retail store, as well as prescriptions filled at the Company’s retail pharmacies under the Maintenance Choice program, which permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.
Contracts With Customers, Assets and Liabilities
The following table provides information about receivables and contract liabilities from contracts with customers:
In millions
September 30,
2019
    
December 31,
2018
Trade receivables (included in accounts receivable, net)
$
6,413

 
$
6,497

Contract liabilities (included in accrued expenses)
72

 
67


During the nine months ended September 30, 2019, the contract liabilities balance includes increases related to customers’ earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:
In millions
 
Balance at December 31, 2018
$
67

Loyalty program earnings and gift card issuances
269

Redemption and breakage
(264
)
Balance at September 30, 2019
$
72


Impact of New Lease Standard on Balance Sheet Line Items
As a result of applying the new lease accounting standard using a modified retrospective method, the following adjustments were made to accounts on the condensed consolidated balance sheet as of January 1, 2019:
 
 
Impact of Change in Accounting Policy
In millions
 
As Reported
December 31, 2018
 
Adjustments
 
As Adjusted
January 1, 2019
Condensed Consolidated Balance Sheets:
 
 
 
 
 
 
Other current assets
 
$
4,581

 
$
(48
)
 
$
4,533

Total current assets
 
45,243

 
(48
)
 
45,195

Property and equipment, net
 
11,349

 
11

 
11,360

Operating lease right-of-use assets
 

 
20,987

 
20,987

Intangible assets, net
 
36,524

 
(217
)
 
36,307

Other assets
 
5,046

 
(521
)
 
4,525

Total assets
 
196,456

 
20,212

 
216,668

Accrued expenses
 
10,711

 
(52
)
 
10,659

Current portion of operating lease liabilities
 

 
1,803

 
1,803

Current portion of long-term debt
 
1,265

 
2

 
1,267

Total current liabilities
 
44,009

 
1,753

 
45,762

Long-term operating lease liabilities
 

 
18,832

 
18,832

Long-term debt
 
71,444

 
(96
)
 
71,348

Deferred income taxes
 
7,677

 
63

 
7,740

Other long-term liabilities
 
2,780

 
(518
)
 
2,262

Total liabilities
 
137,913

 
20,034

 
157,947

Retained earnings
 
40,911

 
178

 
41,089

Total CVS Health shareholders’ equity
 
58,225

 
178

 
58,403

Total shareholders’ equity
 
58,543

 
178

 
58,721